Overcoming 10 Barriers to Participating in Clinical Trials
We put together a list of some of the most common perceived barriers to participating in clinical trials, and how to overcome them.
Continue ReadingWe put together a list of some of the most common perceived barriers to participating in clinical trials, and how to overcome them.
Continue ReadingCour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a…
Continue ReadingMany people who suspect they have celiac disease choose to start a gluten-free diet right away, without a formal diagnosis. Here's why you shouldn't.
Continue ReadingParents using multiple kitchen appliances and utensils to prevent their child with celiac disease from being exposed to gluten may be able to eliminate some cumbersome steps. A new, preliminary…
Continue ReadingCEO Marilyn G. Geller’s testimony before the House Appropriations Subcommittee has helped secure report language in the House’s version of the 2020 Labor-HHS-Education bill demanding that the National Institute of…
Continue ReadingThe Celiac Disease Foundation is excited to announce a new relationship with Celiac Cruise to offer a gluten-free sailing experience in the Caribbean and Europe.
Continue ReadingOn August 29, 2019, the Celiac Disease Foundation’s 7th Annual New York Golf Outing was held at the New York Country Club in New Hempstead, NY.
Continue ReadingCEO Marilyn G. Geller speaks at the 18th International Celiac Disease Symposium (ICDS).
Continue ReadingActoBio announces FDA has given permission to an Investigational New Drug (IND) application for Actobiotics® AG017, a therapeutic candidate for celiac disease.
Continue ReadingJulie McCormack discusses her annual AITI Golf Outing and why she continues to be a Celiac Disease Foundation top Team Gluten-Free fundraiser.
Continue Reading